Report Cover

United States Glaucoma Treatment Market Report & Forecast 2021-2027


United States Glaucoma Treatment Market, By Product, 2016-2021, 2022-2027 ($ Millions)
United States Glaucoma Treatment Market Segment Percentages, By Product, 2020 (%)
    Prostaglandin Analogs (PGAs)
    Beta Blocker
    Alpha Agonist
    Others

United States Glaucoma Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions)
United States Glaucoma Treatment Market Segment Percentages, By Application, 2020 (%)
    Clinic
    Pharmacy
    Other

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glaucoma Treatment revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Glaucoma Treatment revenues share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Novartis
    Allergan
    Pfizer
    Akorn
    Teva
    Bausch & Lomb
    Otsuka Pharmaceutical
    Santen
    Lunan Pharma
    Zizhu Pharma
1 Introduction to Research & Analysis Reports
    1.1 Glaucoma Treatment Market Definition
    1.2 Market Segments
        1.2.1 Segment by Product
        1.2.2 Segment by Application
    1.3 United States Glaucoma Treatment Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Glaucoma Treatment Overall Market Size
    2.1 United States Glaucoma Treatment Market Size: 2021 VS 2027
    2.2 United States Glaucoma Treatment Revenue, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints

3 Company Landscape
    3.1 Top Glaucoma Treatment Players in United States Market
    3.2 Top United States Glaucoma Treatment Companies Ranked by Revenue
    3.3 United States Glaucoma Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Glaucoma Treatment Companies in United States Market, by Revenue in 2020
    3.5 Companies Glaucoma Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Glaucoma Treatment Players in United States Market
        3.6.1 List of Tier 1 Glaucoma Treatment Companies in United States
        3.6.2 List of Tier 2 and Tier 3 Glaucoma Treatment Companies in United States

4 Sights by Product
    4.1 Overview
        4.1.1 By Product - United States Glaucoma Treatment Market Size Markets, 2021 & 2027
        4.1.2 Prostaglandin Analogs (PGAs)
        4.1.3 Beta Blocker
        4.1.4 Alpha Agonist
        4.1.5 Others
    4.2 By Product - United States Glaucoma Treatment Revenue & Forecasts
        4.2.1 By Product - United States Glaucoma Treatment Revenue, 2016-2021
        4.2.2 By Product - United States Glaucoma Treatment Revenue, 2022-2027
        4.2.3 By Product - United States Glaucoma Treatment Revenue Market Share, 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Glaucoma Treatment Market Size, 2021 & 2027
        5.1.2 Clinic
        5.1.3 Pharmacy
        5.1.4 Other
    5.2 By Application - United States Glaucoma Treatment Revenue & Forecasts
        5.2.1 By Application - United States Glaucoma Treatment Revenue, 2016-2021
        5.2.2 By Application - United States Glaucoma Treatment Revenue, 2022-2027
        5.2.3 By Application - United States Glaucoma Treatment Revenue Market Share, 2016-2027

6 Glaucoma Treatment Companies Profiles
    6.1 Novartis
        6.1.1 Novartis Company Details
        6.1.2 Novartis Business Overview
        6.1.3 Novartis Glaucoma Treatment Introduction
        6.1.4 Novartis Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.1.5 Novartis Recent Developments
    6.2 Allergan
        6.2.1 Allergan Company Details
        6.2.2 Allergan Business Overview
        6.2.3 Allergan Glaucoma Treatment Introduction
        6.2.4 Allergan Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.2.5 Allergan Recent Developments
    6.3 Pfizer
        6.3.1 Pfizer Company Details
        6.3.2 Pfizer Business Overview
        6.3.3 Pfizer Glaucoma Treatment Introduction
        6.3.4 Pfizer Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.3.5 Pfizer Recent Developments
    6.4 Akorn
        6.4.1 Akorn Company Details
        6.4.2 Akorn Business Overview
        6.4.3 Akorn Glaucoma Treatment Introduction
        6.4.4 Akorn Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.4.5 Akorn Recent Developments
    6.5 Teva
        6.5.1 Teva Company Details
        6.5.2 Teva Business Overview
        6.5.3 Teva Glaucoma Treatment Introduction
        6.5.4 Teva Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.5.5 Teva Recent Developments
    6.6 Bausch & Lomb
        6.6.1 Bausch & Lomb Company Details
        6.6.2 Bausch & Lomb Business Overview
        6.6.3 Bausch & Lomb Glaucoma Treatment Introduction
        6.6.4 Bausch & Lomb Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.6.5 Bausch & Lomb Recent Developments
    6.7 Otsuka Pharmaceutical
        6.7.1 Otsuka Pharmaceutical Company Details
        6.7.2 Otsuka Pharmaceutical Business Overview
        6.7.3 Otsuka Pharmaceutical Glaucoma Treatment Introduction
        6.7.4 Otsuka Pharmaceutical Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.7.5 Otsuka Pharmaceutical Recent Developments
    6.8 Santen
        6.8.1 Santen Company Details
        6.8.2 Santen Business Overview
        6.8.3 Santen Glaucoma Treatment Introduction
        6.8.4 Santen Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.8.5 Santen Recent Developments
    6.9 Lunan Pharma
        6.9.1 Lunan Pharma Company Details
        6.9.2 Lunan Pharma Business Overview
        6.9.3 Lunan Pharma Glaucoma Treatment Introduction
        6.9.4 Lunan Pharma Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.9.5 Lunan Pharma Recent Developments
    6.10 Zizhu Pharma
        6.10.1 Zizhu Pharma Company Details
        6.10.2 Zizhu Pharma Business Overview
        6.10.3 Zizhu Pharma Glaucoma Treatment Introduction
        6.10.4 Zizhu Pharma Glaucoma Treatment Revenue in United States Market (2016-2021)
        6.10.5 Zizhu Pharma Recent Developments

7 Conclusion
8 Appendix
    8.1 Note
    8.2 Examples of Clients
    8.3 Author Details
    8.4 Disclaimer

List of Tables Table 1. Glaucoma Treatment Market Opportunities & Trends in United States Market Table 2. Glaucoma Treatment Market Drivers in United States Market Table 3. Glaucoma Treatment Market Restraints in United States Market Table 4. Key Players of Glaucoma Treatment in United States Market Table 5. Top Glaucoma Treatment Players in United States Market, Ranking by Revenue (2019) Table 6. United States Glaucoma Treatment Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Glaucoma Treatment Revenue Share by Companies, 2016-2021 Table 8. Companies Glaucoma Treatment Product Product Table 9. List of Tier 1 Glaucoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Glaucoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Product - United States Glaucoma Treatment Revenue, (US$, Mn), 2021 & 2027 Table 12. By Product - United States Glaucoma Treatment Revenue (US$, Mn), 2016-2021 Table 13. By Product - United States Glaucoma Treatment Revenue (US$, Mn), 2022-2027 Table 14. By Application - United States Glaucoma Treatment Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Glaucoma Treatment Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Glaucoma Treatment Revenue (US$, Mn), 2022-2027 Table 17. Novartis Company Details Table 18. Novartis Business Overview Table 19. Novartis Glaucoma Treatment Product Table 20. Novartis Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Novartis Recent Developments Table 22. Allergan Company Details Table 23. Allergan Business Overview Table 24. Allergan Glaucoma Treatment Product Table 25. Allergan Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Allergan Recent Developments Table 27. Pfizer Company Details Table 28. Pfizer Business Overview Table 29. Pfizer Glaucoma Treatment Product Table 30. Pfizer Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Pfizer Recent Developments Table 32. Akorn Company Details Table 33. Akorn Business Overview Table 34. Akorn Glaucoma Treatment Product Table 35. Akorn Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Akorn Recent Developments Table 37. Teva Company Details Table 38. Teva Business Overview Table 39. Teva Glaucoma Treatment Product Table 40. Teva Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Teva Recent Developments Table 42. Bausch & Lomb Company Details Table 43. Bausch & Lomb Business Overview Table 44. Bausch & Lomb Glaucoma Treatment Product Table 45. Bausch & Lomb Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Bausch & Lomb Recent Developments Table 47. Otsuka Pharmaceutical Company Details Table 48. Otsuka Pharmaceutical Business Overview Table 49. Otsuka Pharmaceutical Glaucoma Treatment Product Table 50. Otsuka Pharmaceutical Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Otsuka Pharmaceutical Recent Developments Table 52. Santen Company Details Table 53. Santen Business Overview Table 54. Santen Glaucoma Treatment Product Table 55. Santen Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 56. Santen Recent Developments Table 57. Lunan Pharma Company Details Table 58. Lunan Pharma Business Overview Table 59. Lunan Pharma Glaucoma Treatment Product Table 60. Lunan Pharma Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 61. Lunan Pharma Recent Developments Table 62. Zizhu Pharma Company Details Table 63. Zizhu Pharma Business Overview Table 64. Zizhu Pharma Glaucoma Treatment Product Table 65. Zizhu Pharma Glaucoma Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 66. Zizhu Pharma Recent Developments List of Figures Figure 1. Glaucoma Treatment Segment by Product Figure 2. Glaucoma Treatment Segment by Application Figure 3. United States Glaucoma Treatment Market Overview: 2020 Figure 4. United States Glaucoma Treatment Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Glaucoma Treatment Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Glaucoma Treatment Revenue in 2020 Figure 7. By Product - United States Glaucoma Treatment Revenue Market Share, 2016-2027 Figure 8. By Application - United States Glaucoma Treatment Revenue Market Share, 2016-2027 Figure 9. Novartis Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Allergan Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Pfizer Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Akorn Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Teva Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Bausch & Lomb Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Otsuka Pharmaceutical Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Santen Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. Lunan Pharma Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. Zizhu Pharma Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us